TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21510583

Group type: EXPERIMENTAL
Intervention: Blend of rice bran oil and safflower oil (80% rice bran oil and 20% safflower oil)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control oil (the oil which the patient was using before)
Number of subjects: 73
Study: 18797483

Group type: EXPERIMENTAL
Intervention: Primary care record ethnicity data
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Non-New Zealand European ethnic group
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: New Zealand European ethnic group
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Maori respondents
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Misclassification impact on Maori, Pacific, and Indian subcontinent peoples
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Other ethnicities
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: PREDICT tool with ethnicity data categorised using Statistics New Zealand prioritisation rules
Number of subjects: 665
Study: 16213855

Group type: EXPERIMENTAL
Intervention: Cook K‐Jet embryo transfer catheter
Number of subjects: 150

Group type: COMPARATOR
Intervention: Wallace embryo transfer catheter
Number of subjects: 150
Study: 12025527

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg once daily
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily
Number of subjects: 313

Group type: COMPARATOR
Intervention: Diclofenac 75 mg twice daily
Number of subjects: 313
Study: 8126353

Group type: EXPERIMENTAL
Intervention: 10-hour balance training program manipulating sensory inputs from visual, vestibular, and somatosensory systems
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 2544119

Group type: EXPERIMENTAL
Intervention: Etomidate infusion (16.8 +/- 3.0 mg.kg‐1.min‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (1 to 1.5 vol% enflurane in a nitrous oxide‐oxygen mixture)
Number of subjects: 12
Study: 31031097

Group type: EXPERIMENTAL
Intervention: INPUT education program under RCT conditions
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: INPUT education program under IT conditions
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: INPUT education program under both RCT and IT conditions
Number of subjects: 135
Study: 28493293

Group type: EXPERIMENTAL
Intervention: Oral prednisolone for 2 weeks
Number of subjects: 117
Study: 25854635

Group type: EXPERIMENTAL
Intervention: Levetiracetam 500 mg/day
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Levetiracetam 1000 mg/day
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Levetiracetam 2000 mg/day
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Levetiracetam 3000 mg/day
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study: 23711549

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21863617

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of ephedrine (50 mg/500 ml of Ringer solution)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Preoperative hydration with 20 ml/kg of Ringer solution
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of ephedrine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 19391528

Group type: EXPERIMENTAL
Intervention: Moxibustion combined with intermittent urethral catheterization
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine intermittent urethral catheterization
Number of subjects: 76
Study: 17187936

Group type: EXPERIMENTAL
Intervention: Self-report of abstinence from alcohol
Number of subjects: 253

Group type: COMPARATOR
Intervention: Partner reports of women's abstinence from alcohol
Number of subjects: 253

Group type: COMPARATOR
Intervention: Post-partum agreement between dyads
Number of subjects: 253
Study: 15489205

Group type: EXPERIMENTAL
Intervention: Dietary intervention assessed through a 5-day dietary record (DR) and food-frequency questionnaire (FFQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary intervention assessed through FFQ
Number of subjects: 0
Study: 11564387

Group type: EXPERIMENTAL
Intervention: Propafenone (mean daily dose 13 +/- 1.5 mg/kg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sotalol (mean daily dose 3 +/- 0.4 mg/kg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Propafenone and Sotalol
Number of subjects: 300
Study: 9692539

Group type: EXPERIMENTAL
Intervention: Sperm deformity index
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Multiple anomalies index
Number of subjects: 94
Study: 8186281

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 32
Study: 2491468

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine b.d.
Number of subjects: 336

Group type: COMPARATOR
Intervention: 300 mg ranitidine nocte
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 336
Study: 955495

Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cholic acid or placebo
Number of subjects: 66
Study: 31412092

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 28795185

Group type: EXPERIMENTAL
Intervention: Perceived work-induced lumbar exertion
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Multi-site pain
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Work-related fear-avoidance beliefs (FAB-W)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Lumbar exertion
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: FAB-W
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Physical performance in figure-of-eight running
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Modified push-ups
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Recovery after work
Number of subjects: 219
Study: 25747197

Group type: EXPERIMENTAL
Intervention: Trebananib 10 mg/kg once weekly plus paclitaxel and bevacizumab (Arm A)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Trebananib 3 mg/kg once weekly plus paclitaxel and bevacizumab (Arm B)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel and bevacizumab (Arm C)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Open-label trebananib 10 mg/kg once weekly plus paclitaxel (Arm D)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Open-label trebananib 10 mg/kg once weekly (Arm D) with high exposure
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Open-label trebananib 10 mg/kg once weekly (Arm D) with low exposure
Number of subjects: 228
Study: 23167499

Group type: EXPERIMENTAL
Intervention: Supervised Tai Chi exercises
Number of subjects: 152

Group type: COMPARATOR
Intervention: Conventional physical therapy exercises
Number of subjects: 152
Study: 23159551

Group type: EXPERIMENTAL
Intervention: ICD‐CRT
Number of subjects: 1798

Group type: COMPARATOR
Intervention: ICD only
Number of subjects: 1798
Study: 20112576

Group type: EXPERIMENTAL
Intervention: Chinese herbs promoting blood circulation and removing blood stasis (Caesalpinia Sappan 10 g, Ligusticum Chuanxiong 6 g, Frankincense 6 g, Angelica 10 g, Safflower 6 g, Myrrh 6 g, Ground Beetle 10 g, Araliaceae 3 g, Radix Paeoniae Rubra 10 g, Pericarpium Citri Reticulatae 5 g, Lawn Pennywort Herb 15 g, Manis Pentadactyla 10 g, Corydalis Yanhusuo 10 g, Rhizoma Drynariae 15 g) taken orally for 10 days, and external application of traditional medicine for fuming and washing limbs twice daily.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo of the same color for oral use and external application, with the same delivery times and therapy duration as the treatment group.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Chinese herbs promoting blood circulation and removing blood stasis (same as above).
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (same as above).
Number of subjects: 58
Study: 17225034

Group type: EXPERIMENTAL
Intervention: Counselling in the home setting
Number of subjects: 36

Group type: COMPARATOR
Intervention: Outpatient rehabilitation
Number of subjects: 36
Study: 15127282

Group type: EXPERIMENTAL
Intervention: Structured pain education (10‐15 min per day for 5 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 30
Study: 11772964

Group type: EXPERIMENTAL
Intervention: FOBT screening (group 1)
Number of subjects: 3548

Group type: COMPARATOR
Intervention: Refusers (group 2)
Number of subjects: 3548
Study: 9851958

Group type: EXPERIMENTAL
Intervention: Vagal maneuvers
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver
Number of subjects: 133
Study: 7986160

Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride (nonselective beta 1‐ and beta 2‐blocker)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metoprolol tartrate (selective beta 1‐blocker)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no beta-blocker)
Number of subjects: 16
Study: 2623708

Group type: EXPERIMENTAL
Intervention: Preventive care program in dental practice, details on dosage and duration not specified.
Number of subjects: 0
Study: 1184719

Group type: EXPERIMENTAL
Intervention: Clonidine (0.15 mg iv)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Apomorphine (selective dopamine receptor agonist)
Number of subjects: 6
Study: 31609315

Group type: EXPERIMENTAL
Intervention: Olive-oil-based three-chamber bags (3CBs)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Soybean-oil-based compounded bags (CoBs)
Number of subjects: 458
Study: 29358855

Group type: COMPARATOR
Intervention: 30 min ischemia followed by 30 min reperfusion (30I30R)
Number of subjects: 1

Group type: COMPARATOR
Intervention: 30 min ischemia followed by 120 min reperfusion (30I120R)
Number of subjects: 1

Group type: COMPARATOR
Intervention: 30 min ischemia (30I)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Citrulline concentrations
Number of subjects: 1
Study: 26165582

Group type: EXPERIMENTAL
Intervention: Diabetes Self-Management Program
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: General Self-Management Program
Number of subjects: 405

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 405
Study: 24221463

Group type: EXPERIMENTAL
Intervention: 33‐gauge injection device without a speculum
Number of subjects: 70

Group type: COMPARATOR
Intervention: 30‐gauge needle using a speculum
Number of subjects: 70
Study: 21485071

Group type: EXPERIMENTAL
Intervention: Chinese drugs for supplementing qi-blood and nourishing Gan-Shen (Cuhuangti Granule and Jinghou Zengzhi Granule)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (standard regimen for promoting ovulation)
Number of subjects: 86
Study: 19430945

Group type: EXPERIMENTAL
Intervention: Treadmill exercise bout (65% V(O)(2max); 600 kcal expended)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 18
Study: 16570008

Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ganciclovir and immunoglobulin (IG)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ganciclovir and IG
Number of subjects: 34
Study: 12742279

Group type: EXPERIMENTAL
Intervention: Ximelagatran 20 mg twice daily
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Ximelagatran 40 mg twice daily
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Ximelagatran 60 mg twice daily
Number of subjects: 254

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 254
Study: 10858869

Group type: EXPERIMENTAL
Intervention: Cardiodoron (herbal extract composition)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 9222232

Group type: EXPERIMENTAL
Intervention: Short-wavelength sensitivity measurement
Number of subjects: 172
Study: 8477130

Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Nitrazepam
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control
Number of subjects: 123
Study: 2947105

Group type: EXPERIMENTAL
Intervention: Tentative protocol combining multiple individual assessments with validated scales and tests.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 29428831

Group type: EXPERIMENTAL
Intervention: LOP technique
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard pneumatic ischemia technique
Number of subjects: 160
Study: 26699670

Group type: EXPERIMENTAL
Intervention: PEAS-Diet (interview-administered version)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 361
Study: 24885132

Group type: EXPERIMENTAL
Intervention: Surgical antimicrobial prophylaxis administered in the anesthesia room (75 to 30 minutes before incision)
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Surgical antimicrobial prophylaxis administered in the operating room (less than 30 minutes before incision)
Number of subjects: 5000
Study: 22457015

Group type: EXPERIMENTAL
Intervention: Clevidipine (2.0 mg/h, titrated to target dose up to 16.0 mg/h)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 19673922

Group type: EXPERIMENTAL
Intervention: Early loading (overdenture connected 1 week after surgery)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Delayed loading (overdenture connected 3 months after surgery)
Number of subjects: 26
Study: 17431817

Group type: EXPERIMENTAL
Intervention: LCPUFA supplementation (AA 0.46 wt%, DHA 0.27 wt%)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Phenylalanine-free amino acid supplements without LCPUFA
Number of subjects: 21
Study: 15608499

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol-enriched rinse-off product (test product, TP)
Number of subjects: 13

Group type: COMPARATOR
Intervention: alpha-tocopherol-free vehicle control (control product, CP)
Number of subjects: 13
Study: 12366781

Group type: EXPERIMENTAL
Intervention: CA genotype at position -607 in sarcoidosis patients
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: C allele at position -607 in sarcoidosis patients
Number of subjects: 119

Group type: COMPARATOR
Intervention: Genotype distribution at position -137
Number of subjects: 119
Study: 9895042

Group type: EXPERIMENTAL
Intervention: Endoscopy
Number of subjects: 154

Group type: COMPARATOR
Intervention: No endoscopy
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Endoscopy and No endoscopy
Number of subjects: 154
Study: 7625106

Group type: EXPERIMENTAL
Intervention: Recombinant DNA yeast-derived HB vaccine booster dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four doses of primary immunization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three doses of primary immunization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary immunization (overall)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age-related antibody levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booster dose
Number of subjects: 0
Study: 2204779

Group type: EXPERIMENTAL
Intervention: Recent advances in management of diabetic retinal vascular disease
Number of subjects: 0
Study: 357071

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg 3 times a day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg 3 times a day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Metoclopramide 30 mg daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31756389

Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 1771

Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 1771

Group type: EXPERIMENTAL
Intervention: Heart failure increment by 2 classes
Number of subjects: 1771

Group type: EXPERIMENTAL
Intervention: AF presence during follow-up
Number of subjects: 1771

Group type: EXPERIMENTAL
Intervention: Ventricular rate >80 beats/min
Number of subjects: 1771

Group type: EXPERIMENTAL
Intervention: Higher frequency of recorded AF in rhythm arm
Number of subjects: 1771
Study: 30659286

Group type: EXPERIMENTAL
Intervention: Aquatic therapy
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Robotic therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Comparison of both interventions
Number of subjects: 31
Study: 27590629

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (walking, resistance training, and flexibility exercises)
Number of subjects: 1476

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 1476

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1476
Study: 26190153

Group type: EXPERIMENTAL
Intervention: Pasta enriched with 35% faba bean dried at a very high temperature
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pasta enriched with 35% faba bean dried at a low temperature
Number of subjects: 15

Group type: COMPARATOR
Intervention: Durum wheat pasta dried at a low temperature (control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pasta enriched with 35% faba bean dried at a high temperature
Number of subjects: 15
Study: 24851582

Group type: EXPERIMENTAL
Intervention: Walking exercise program applying the Theory of Planned Behavior
Number of subjects: 68

Group type: COMPARATOR
Intervention: Health information and booklet practice
Number of subjects: 68
Study: 21285450

Group type: EXPERIMENTAL
Intervention: Mild CKD (prepregnancy Cr < 125 µmol/Cr > 100 µmol at booking; n = 22)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Moderate/severe CKD (prepregnancy creatinine > 125 µmol; n = 14)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Proteinuria (≥2+) with concomitant risk of PE
Number of subjects: 66
Study: 19573478

Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 165

Group type: COMPARATOR
Intervention: Aerobic training
Number of subjects: 165

Group type: COMPARATOR
Intervention: Cognitive abilities
Number of subjects: 165
Study: 15818296

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 192
Study: 12441754

Group type: EXPERIMENTAL
Intervention: NPPV
Number of subjects: 6

Group type: COMPARATOR
Intervention: 10 cm H2O CPAP
Number of subjects: 6

Group type: COMPARATOR
Intervention: 5 cm H2O CPAP
Number of subjects: 6
Study: 10527972

Group type: EXPERIMENTAL
Intervention: Conventional in-vitro fertilization (IVF)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as the comparison between IVF and ICSI)
Number of subjects: 56
Study: 9395631

Group type: EXPERIMENTAL
Intervention: Sambucol (SAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1953974

Group type: EXPERIMENTAL
Intervention: Rice-powder gruel (RPG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Oral rehydration salts (ORS)
Number of subjects: 70
Study: 7468619

Group type: EXPERIMENTAL
Intervention: diet plus tolazamide
Number of subjects: 25

Group type: COMPARATOR
Intervention: diet plus placebo
Number of subjects: 25
Study: 31264950

Group type: EXPERIMENTAL
Intervention: Intravenous contrast agent administration (CT angiography)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Intra-arterial contrast agent administration (catheterization)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Postcontrast AKI
Number of subjects: 320
Study: 29101842

Group type: EXPERIMENTAL
Intervention: Anodal transcranial Direct Current Stimulation (tDCS) applied to the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 0
Study: 24754705

Group type: EXPERIMENTAL
Intervention: Competitive swim macrocycle (16 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (non-swimmers)
Number of subjects: 49
Study: 23831913

Group type: EXPERIMENTAL
Intervention: 200 mg Q10 daily for 12 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 21183326

Group type: EXPERIMENTAL
Intervention: Aclidinium 200 μg
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 21246788

Group type: EXPERIMENTAL
Intervention: Propiverin 30 mg daily
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combination of propiverin 30 mg daily and tamsulosin 0.4 mg daily
Number of subjects: 28
Study: 17576207

Group type: EXPERIMENTAL
Intervention: Oral delayed release granules
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 60 mL rectal foam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rectal delivery of 5‐ASA
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High peak plasma concentrations of 5‐ASA
Number of subjects: 24
Study: 15076792

Group type: EXPERIMENTAL
Intervention: 4C model (gold standard)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 3Cw model
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Descriptive methods (DXA, BMI, skinfold measurement, bioimpedance)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 3Cb model
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Prediction equation based on BMI
Number of subjects: 27
Study: 12238418

Group type: EXPERIMENTAL
Intervention: Primary coronary stent implantation
Number of subjects: 479

Group type: COMPARATOR
Intervention: Optimal PTCA with provisional stenting
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Primary stent strategy
Number of subjects: 479
Study: 9869017

Group type: EXPERIMENTAL
Intervention: Active treatment (nitrendipine 10-40 mg daily, captopril 12.5-50.0 mg daily, hydrochlorothiazide 12.5-50.0 mg daily)
Number of subjects: 2394

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2394
Study: 8005305

Group type: EXPERIMENTAL
Intervention: GnRH agonist therapy for 12 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: No therapy (Control group)
Number of subjects: 80
Study: 2806500

Group type: EXPERIMENTAL
Intervention: Oxygen-conserving reservoir device (Oxymizer Pendant)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pharyngeal catheter
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nasal prongs
Number of subjects: 36
Study: 985049

Group type: EXPERIMENTAL
Intervention: Clomipramine plus tryptophan
Number of subjects: 24

Group type: COMPARATOR
Intervention: Clomipramine plus placebo
Number of subjects: 24